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Abstract
Malignant mesothelioma (MM) is an almost invariably fatal cancer caused by as-
bestos exposure. The toxicity of asbestos fibers is related to their physicochemical 
properties and the generation of free radicals. We set up a pilot study to investigate 
the potential of the zeolite clinoptilolite to counteract the asbestos carcinogenesis by 
preventing the generation of reactive nitrogen and oxygen radicals. In cell culture 
experiments, clinoptilolite prevented asbestos‐induced cell death, reactive oxygen 
species production, DNA degradation, and overexpression of genes known to be up‐
regulated by asbestos. In an asbestos‐induced transgenic mouse model of MM, mice 
were injected intraperitoneal injections with blue asbestos, with or without clinop-
tilolite, and monitored for 30 weeks. By the end of the trial all 13 mice injected with 
asbestos alone had reached humane end points, whereas only 7 of 29 mice receiving 
crocidolite and clinoptilolite reached a similar stage of disease. Post‐mortem exami-
nation revealed pinpoint mesothelioma‐like tumors in affected mice, and the absence 
of tumor formation in surviving mice. Interestingly, the macrophage clearance sys-
tem, which was largely suppressed in asbestos‐treated mice, exhibited evidence of 
increased phagocytosis in mice treated with asbestos and clinoptilolite. Our study 
suggests that inhibiting the asbestos‐induced generation of reactive oxygen species 
and stimulating the macrophage system may represent a pathway to amelioration of 
asbestos‐induced toxicity. Additional studies are warranted to explore the underlying 
mechanisms responsible for our observations.
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1  |  INTRODUCTION
Asbestos is a naturally occurring fibrous silicate mineral that 
was a popular building material until the late 20th century. 
Asbestos can be classified into two main families: the ser-
pentines, consisting of chrysotile (white asbestos) and am-
phiboles which includes crocidolite (blue asbestos), tremolite 
and amosite.1,2 White asbestos (chrysotile) was specifically 
and widely used in asbestos cement as a building material. 
It was also used, along with other types of asbestos in other 
industrial materials, and in automobile brake linings and as 
insulation for pipes, ducts, electrical goods, and extensively 
in ship building. In all, asbestos was used in more than 3000 
products.1 Although asbestos has been recognized as a human 
carcinogen since 1955,3 the general public only became 
aware of its profound dangers in the 1980s. Despite this, its 
use has been banned in only 66/195 countries, as of March 
2019. Asbestos‐related cancers include lung cancer and ma-
lignant mesothelioma (MM).4,5 MM arises in the mesothelial 
membrane lining the pleura and peritoneum and is consid-
ered a poor‐prognosis cancer.6 There is no cure for MM and 
most patients die within 2 years of diagnosis. Best practice 
palliative chemotherapy yields a mean survival improvement 
of around 3 months.7,8 The incidence of MM is still rising in 
most industrialized countries and will increase in developing 
countries due to continued use of asbestos.9
Multiple studies suggest that iron present in, or adsorbed 
to, asbestos fibers is a key factor for asbestos toxicity and 
the formation of asbestos bodies in the lung that are the hall-
marks of asbestos exposure.2,10,11 Iron from asbestos fibers 
(released as labile Fe3+) catalyzes the generation of reactive 
oxygen and nitrogen species, induces DNA single strand 
breaks, lipid peroxidation, and the release of proinflamma-
tory cytokines, leading to genotoxicity, reduced immune 
responsiveness and, eventually, MM.12-18 The mechanisms 
leading to the development of asbestos‐related cancers are 
complex and poorly understood.
Asbestos‐induced and genetically modified mouse mod-
els have been developed in order to better understand asbes-
tos carcinogenicity in MM. One example is the MexTAg299 
transgenic mouse model, in which the Simian Virus (SV40) 
large T antigen is expressed specifically in mesothelial cells 
under the control of the mesothelial cell‐specific mesothelin 
promoter.19 When exposed to asbestos, these mice develop 
cancers at 100% incidence within 40  weeks, and with tu-
mors that replicate key features of the pathogenesis of human 
MM.20
Zeolites are a group of hydrated natural or synthetic mi-
croporous crystals containing AlO4 and SiO4 tetrahedra, 
linked through common oxygen atoms into rigid anionic cage 
frameworks containing well‐defined channels and cavities, 
which give zeolites a high capacity for ion exchange.21 The 
majority of natural zeolites are of volcanic origin and have the 
general formula, M2/n:Al2O3:xSiO2:yH2O, where M stands 
for the extra‐framework cation. A recent review summarizes 
the origins, structures and properties, and industrial and med-
ical and veterinary uses of natural and synthetic zeolites.22 
An emphasis on the most commonly used zeolite in humans, 
namely clinoptilolite, is combined with hypotheses to explain 
observed positive effects of detoxification, immune response, 
and general health in humans.
Naturally occurring zeolites include those whose bio-
logical and chemical reactivity is reportedly carcinogenic 
(erionite) to essentially non‐toxic (clinoptilolite). Erionite's 
carcinogenic propensity derives from its asbestos‐like fibrous 
structure.23-25 Erionite‐induced mesotheliomas are similar to 
those originating from asbestos in exhibiting biopersistence, 
long latency, histology, and fibrosis. Erionite is listed on the 
American Cancer Society website as a risk factor for MM, 
along with asbestos, SV40, and radiation. Most other zeo-
lites such as clinoptilolite, mordenite, and chabazite have 
non‐toxic, less reactive orthorhombic crystalline structures, 
with accessible open channels for “capturing” or sequester-
ing water and large ions.21,26
The present study began with the notion that the metal‐
binding properties of zeolites would scavenge iron released 
from asbestos fibers and consequently ameliorate asbes-
tos toxicity. Here we demonstrate the moderating effects of 
clinoptilolite on asbestos‐induced cellular damage in vitro 
and asbestos‐induced carcinogenesis in vivo. We discuss the 
potential implications of these findings and the future studies 
needed to understand the mechanisms underlying the asbes-
tos ameliorating effects of clinoptilolite.
2 |  METHODS
2.1 | Preparation of asbestos fibers
White (chrysotile) and blue (crocidolite) asbestos fibers 
were obtained from two sources: The Union for International 
Cancer Control (UICC; Switzerland); and James Hardie 
Industries (Australia). Fiberglass was sourced from Bradford 
Insulation (Sydney, Australia). Fibers in methanol were pro-
cessed in a Fritsch pulverisette23 mini‐mill (Fritsch GmbH, 
Germany) to a uniform size, which was determined by a laser 
particle scanner to average dimensions of 10 µm in length by 
1 µm width. Fiber suspensions were prepared in phosphate‐
buffered saline (PBS) at a pH of 7.4 and stored at 4‐6°C. 
Crocidolite and chrysotile asbestos fibers were diluted to 
concentrations of 10 and 5 mg/mL, respectively, on the day 
of the experiment. Fiberglass was pulverized in a mortar and 
pestle to a fine dust, then suspended in PBS at 10  mg/mL 
and refrigerated. For cell culture experiments, fibers were 
washed twice in cell culture medium without fetal bovine 
serum (FBS) and resuspended in culture medium (without 
FBS) to 1 mg/mL.
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2.2 | Zeolites used in this study
Natural clinoptilolite (NCL) was obtained from St. Cloud. 
Synthetic clinoptilolite (SCL), and synthetic mordenite 
(SMO) were obtained from Novachem. NCL was chosen 
because it is one of the most common and well described 
zeolites. The two synthetic zeolites were chosen to give a 
comparison with NCL in the cell culture experiments. For 
the mouse model trials, only NCL was used. Zeolites were 
ground in a Fritsch mill, scanned, and stored in PBS. The 
milled mean NCL particle size was 4.28 µm for NCL. For 
some assays, SCL and SMO were tested alongside NCL. 
Their milled mean particle sizes were 4.73 and 5.26  µm, 
respectively.
2.3 | Cell culture and treatment with 
fibers or minerals
A549 and MeT‐5A cells were obtained from the American 
Type Culture Collection (ATCC) and stored in liquid nitro-
gen at a density of 1 × 106 cells/mL in 1 mL cryogenic stor-
age vials. Cells cultures were grown in complete medium 
(RPMI1640; Life Technologies), supplemented with 10% 
FBS, and 100 units/mL penicillin and streptomycin, at 37°C 
with 5% CO2. Cells were treated with fiberglass, asbestos, or 
zeolites as required in T25 or T75 flasks or 6‐ 24‐ or 96‐well 
plates. Medium containing asbestos, fiberglass, or zeolites 
was added at concentrations of, 0.5, 1, 2.5, 5, or 10 µg/cm2, 
and incubation continued for 24‐72 h. Cells were then ana-
lyzed for viability, ROS production, DNA fragmentation, or 
gene expression as outlined below.
2.4 | Cell viability assay
When cell confluence reached 70%‐80% in six‐well plates, 
they were treated with blue (crocidolite) or white (chryso-
tile) asbestos (at 5 µg/cm2) with or without natural or SCL, 
or mordenite (all at 10 µg/cm2) for 24‐36 hours, then trypsi-
nized and washed three times in PBS and assayed for viabil-
ity using propidium iodide and scored in a Tali Image‐Based 
Cytometer at nine fields per sample. Each sample was de-
rived from pooled cells from a six‐well plate and each assay 
was repeated three times.
2.5 | Reactive oxygen species assay
A549 or MeT‐5A cells were cultured to 70%‐80% conflu-
ence in six‐well plates, treated with asbestos and/or zeolites 
for 24‐36 hours, as in the viability assays, then treated with 
CellROX Orange (Life Technologies) using the supplier's 
protocol, followed by measurement of ROS fluorescence in a 
Tali Image‐Based Cytometer using the same number of fields 
and pooled cells as in the viability assays. CellROX reagents 
are fluorogenic probes for measuring generalized oxidative 
stress in cells, and were used here to measure levels of ROS 
in response to different treatments. While reagents selective 
for a variety of reactive species targeted to the cytosol or mi-
tochondria are available, these were considered beyond the 
scope of the current study.
2.6 | DNA extraction and gel electrophoresis
A549 cells were seeded at a density of 5.0 × 104 cells/mL 
in T75 flasks and incubated for 24 hours, then treated with 
asbestos, fiberglass, or NCL and incubated for a further 
72 hours. Confluent cells were harvested by trypsinisation, 
centrifuged, and washed in PBS. DNA extraction from PBS 
resuspended cell pellets was performed using Trizol reagent 
(Invitrogen) and the manufacturer's protocol. Final DNA 
pellets were resuspended in 200 µL of 8 mmol/L NaOH and 
quantified in a Nanodrop spectrophotometer. DNA samples 
of 150 ng/µL (~10 µL per well) were run in 1.2% agarose gels 
in TBE buffer (with Gel‐Red), and photographed in UV light.
2.7 | Gene expression analysis with  
RT‐qPCR
We selected two genes (EGR1; IL‐8) known to be induced by 
exposure of A549 cells to crocidolite 27 and used RT‐qPCR 
to monitor changes in gene expression following challenge 
with crocidolite, chrysotile, and NCL. Initially, cells were ti-
trated with 1‐10 µg/cm2 asbestos and changes in expression 
were observed in a dose‐dependent response. Concentrations 
of 5  µg/cm2 crocidolite or chrysotile and 10  µg/cm2 NCL 
were chosen as test concentrations. A549 cells (1 × 106 cells 
in 5 mL complete medium) were seeded into flasks and incu-
bated to achieve 70% confluence at the time of exposure to 
asbestos or NCL. Fresh medium containing asbestos or asbes-
tos and NCL was added and growth continued for 24 hours, 
then cells were washed in PBS. RNA was isolated using 
Trizol (Invitrogen) following the manufacturer's protocol. 
Final RNA pellets were resuspended in RNase‐free water and 
quantified by Nanodrop at 260/230 nm. Reverse transcription 
was performed on total RNA (2 µg) using the High Capacity 
cDNA reverse transcription kit (Applied Biosystems) ac-
cording to the supplier's instructions. Comparative RT‐qPCR 
was performed on cDNA using TaqMan Gene Expression 
Master Mix (Applied Biosystems) and EGR1‐ and IL‐8‐spe-
cific primers, with 18S RNA used as reference to estimate 
fold‐changes in EGR1 or IL‐8 expression.
2.8 | Transgenic mice and asbestos‐induced 
MM trial
The trials were conducted essentially as described,20 with 
mixed‐sex MexTAg299h transgenic mice at 17‐19  weeks 
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age. They were fed a basal diet and given water ad libitum. 
Intraperitoneal injections (i.p.) were given as follows: Control 
subgroups of three mice were injected with normal saline 
or with NCL (90 mg/kg) weekly. Twelve mice were given 
crocidolite (120 mg/kg; approx. 3 mg per injection; weeks 1 
and 4). Eighteen mice were given crocidolite (weeks 1 and 4) 
plus NCL (30 or 90 mg/kg) weekly. Six mice were given cro-
cidolite (weeks 1 and 4) plus NCL (30 mg/kg) weekly until 
week 10). Six mice were given crocidolite (weeks 1 and 4) 
then NCL (30 mg/kg) weekly from week 10. This protocol 
of injections was designed to test the ability of NCL given 
at the same time as asbestos to delay or prevent the onset 
of MM; given at the same time then withdrawn to test the 
time span of any protective effect of NCL; or given 10 weeks 
after the first asbestos injection to test NCL as a moderator 
of the process of MM tumor development that may have al-
ready begun. Complete post‐mortem data for the two trials 
are given in Tables S1 and S2. Asbestos fibers and NCL were 
prepared in saline on the days of the injections. Mice were 
monitored for general well‐being and weighed daily until hu-
mane endpoints were reached, defined as rapid weight loss or 
gain, distension of the gut, hunching of the back, and signs 
of sickness, distress, or loss of mobility. Survival was taken 
from the date of the first injection. Mice were terminated by 
CO2 asphyxia. Mouse trials had Institutional Biosafety and 
Animal Care & Ethics Committees clearances and were car-
ried out according to standard operating protocols.
2.9 | Histology
Tissue samples were fixed in 4% paraformaldehyde in PBS 
for 24 hours and preserved in 70% ethanol until processed 
into paraffin blocks. Five micrometer sections were cut 
from paraffin blocks, dewaxed in xylene and rehydrated in 
a graded series of alcohols. The dewaxed sections were then 
subjected to either haematoxylin and eosin staining or Perl's 
iron staining. Crocidolite fibers were counted under 40× 
magnification after Perl's iron staining. For each section, 10 
consecutive fields along the peritoneum were chosen to count 
intact fibers, and another 10 consecutive tissue fields adjacent 
to the peritoneum were chosen to count phagocytotic fibers. 
For each mouse, 10 consecutive sections on the same levels 
were cut, and three of the 10 sections were chosen randomly 
for fiber counts. The averaged total numbers of the fibers in 
each set of 10 fields (at 40×) were recorded and plotted. All 
mice were sectioned as above, with three from each subgroup 
chosen at random for the counts.
2.10 | Immunohistochemistry
Immunohistochemistry was performed by modifications of 
several methods.20,28,29 The SV40 pAb 101 antibody (Santa 
Cruz Biotechnology) was applied to the deparaffinized 
sections at 1:100 dilution at 4°C in a moist chamber over-
night; and detected using a biotinylated horse anti‐mouse 
IgG (Vector Laboratories) with the Avidin‐Biotin‐Enzyme 
Complex (Vector Laboratories) and diaminobenzamidine 
(Sigma‐Aldrich) as described previously.30 Samples were 
counter‐stained in Mayer's hematoxylin before embedding 
in DEPEX. SV‐40 positive mesothelial cells and Kupffer 
cells were counted under 40× magnification after immune 
staining. For each section, 10 consecutive fields along the 
peritoneum were chosen to count SV‐40 positive mesothe-
lial cells, and another ten consecutive tissue fields adjacent to 
the peritoneum were chosen to count SV‐40 positive Kupffer 
cells. For each animal, three of the 10 consecutive sections 
on the same level were chosen randomly for cell counts. The 
averaged total numbers of cells in each set of 10 fields were 
recorded as the final result.
2.11 | Statistical analyses
Statistical analysis was performed using spss 19.0 and 
Graphpad Prism 6.02 software. Kaplan Meier survival curves 
(Fig. 5) were calculated and plotted using Graphpad Prism. 
Cell culture experiments were performed in triplicate and re-
peated two to four times. Data in the figures of the mouse 
trial are provided as means ± SEM, where P < .05 was con-
sidered significant. Statistical comparisons in cell culture 
experiments were performed using one‐way ANOVA with 
Bonferroni post hoc test to analyze group differences, and 
the probability of P  <  .05 was considered significant. The 
two‐way ANOVA with Sidak's post‐test was used to analyze 
group differences in the mouse trial for organ cell counts 
from histology and immunohistochemistry slides. The size 
of the mouse subgroups (n = 6) was determined by statisti-
cal analysis using GPower 3.1 analysis (http://www.gpower.
hhu.de/en.htm), assuming a z‐test to compare proportions at 
a significance level of 0.05. A sample size of six mice in each 
treatment subgroup was sufficient to provide over 80% power 
to detect the difference between these groups using a two‐
tailed test, with the exception of the control group in Trial 1 
which had only three mice.
3 |  RESULTS
3.1 | Zeolites moderate the effects of 
asbestos fibers in human lung cell lines
In both lung adenocarcinoma (A549) and mesothelial 
(MeT‐5A) cell lines, asbestos‐induced cellular toxicity, in-
crease in ROS, genomic DNA degradation, and overexpres-
sion of genes up‐regulated by asbestos, were ameliorated 
by co‐administered zeolites, namely NCL, SCL, or SMO. 
The origins and uses of these three zeolites and the reasons 
for using them in this study is discussed at the beginning of 
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Section 2. The surviving fraction of cells was <10% after 
chrysotile or crocidolite exposure but increased significantly 
(>60%; P < .0001) when NCL, SCL, or SMO were included 
(Fig. 1). A549 or MeT‐5A cells treated with each of the three 
zeolites alone, at up to 10 times the level used in the viability 
assay, showed them to be essentially non‐toxic (Fig. S1).
The considerable increase in ROS levels in A549 and 
MeT‐5A cells after asbestos exposure was prevented by 
the simultaneous presence of zeolites (Fig. 2). An increase 
of ROS in asbestos‐treated cells and downstream stress re-
sponses are well‐documented,14,31,32 as is its reversal with 
iron chelating agents or hydroxyl radical scavengers.33 The 
high iron content of asbestos appears to be critical to the 
genesis of ROS, which is chiefly manifested as the highly 
reactive hydroxyl radical (HO˙) from H2O2 with oxidation 
of ferrous iron (Fe2+) to ferric iron (Fe3+) via the Fenton 
reaction.24
Genomic DNA from A459 cells was heavily degraded in 
cells exposed to chrysotile or crocidolite fibers, but largely 
intact in cells exposed to asbestos plus NCL (Fig. 3). DNA 
was not affected by NCL alone or fiberglass, suggesting that 
NCL moderates the cascade of downstream events initiated 
by the presence of asbestos fibers. DNA degradation is typ-
ical in cells exposed to asbestos fibers,31 and this is a first 
instance of inhibition of the degradation process by the co‐
presence of clinoptilolite.
Crocidolite is known for its capacity to significantly alter 
the A549 transcriptome,27 affecting a multiplicity of func-
tions including apoptosis and cell proliferation. We selected 
IL‐8 and EGR1 from this dataset because their expression 
F I G U R E  1  Zeolites ameliorate toxic effects of asbestos fibers in vitro. Viability of A549 (A) and MeT‐5A (B) cells subjected to various 
treatments. Untreated cells (Utr) and those treated with chrysotile (Chr) or crocidolite (Cro) are as labeled. Effects of asbestos were reduced in 
cells additionally treated with natural clinoptilolite (NCL), synthetic clinoptilolite (SCL), or synthetic mordenite (SMO). Data were pooled from 
triplicate experiments repeated three times; and the percentage survival normalized to untreated cells. Crocidolite or chrysotile was added at 5 µg/
cm2 with or without natural or synthetic clinoptilolite, or mordenite (all at 10 µg/cm2) for 24‐36 hr Viability plots for zeolites alone were not shown 
in this figure as the survival levels were near identical (within a few percent) of untreated cells (Utr). However, viability plots for all three zeolites 
are given in Fig. S1
F I G U R E  2  Reactive oxygen species (ROS), detected as increase in fluorescence, was measured in a Tali Cytometer. Percentage ROS was 
expressed as a percentage of stained/unstained cells and plotted for A549 (A) and MeT‐5A (B) cells subjected to various treatments. Legend as in 
Fig. 1. Crocidolite or chrysotile was added at 5 µg/cm2 with or without natural or synthetic clinoptilolite, or mordenite (all at 10 µg/cm2) for 24‐36 h
F I G U R E  3  Agarose gel electrophoretic analysis of genomic 
DNA from A549 cells after 72 h treatment with fiberglass (Fib), 
chrysotile (Chr), or crocidolite (Cro), all at 5 µg/cm2, with or without 
natural clinoptilolite (NCL) at 10 µg/cm2. Upward facing white arrows 
indicate the degraded DNA lanes for asbestos alone
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levels were among the most highly up‐regulated. We found 
that they were overexpressed five to 20‐fold in A549 cells ex-
posed to chrysotile or crocidolite but remained nearer control 
levels when NCL was also present (Fig. 4). The asbestos‐in-
duced increase in expression of IL‐8 and EGR1 seen here 
were similar to levels seen in the full transcriptome study.27 
The characterization of the genomic and epigenetic landscape 
of mesothelioma using diverse high‐throughput technologies 
has been reviewed recently.34 It identified a vast spectrum of 
coding and non‐coding transcriptome changes driving meso-
thelioma development, but only a fraction of this landscape 
has been identified by specific mechanistic changes and sev-
eral of these are common to human cancer development.
In all these in vitro experiments, the commensurate pres-
ence of natural or synthetic zeolites alleviated asbestos tox-
icity similarly in two cell lines—A549 and MeT‐5A—of 
different origin. To explore this further, we envisage addi-
tional in vitro experiments using mesothelioma specific cell 
lines.
3.2 | Zeolites moderate the effects of 
asbestos fibers in a mouse model of MM
The marked protection against asbestos toxicity afforded 
by zeolites in vitro led us to investigate their effects in an 
animal model of MM. After injection with crocidolite, all 13 
MexTAg299 mice developed tumors in the abdominal cavity 
(Fig. 5), consistent with the first description of this model.20 
In contrast, only five of the 18 crocidolite plus NCL‐treated 
mice developed tumors before the end of the trial at week 
30. The early and late NCL subgroups had 1 and 2 mice 
with tumors, respectively, of 11 mice in total for these sub-
groups. There were no MM tumors in the control saline or 
NCL mouse subgroups of three mice each, and prolonged 
NCL injections were well tolerated (Tables S1 and S2 for 
complete post‐mortem results). Ascites fluid, occasionally 
bloody, was present in all asbestos‐treated mice, but not in 
the zeolite group. Interestingly, large volumes of ascitic fluid 
are often found in humans with peritoneal MM.35 The com-
bined results in Fig. 5A are depicted as Kaplan Meier plots 
(Fig. 5B), which track the surviving treated mice over the 
30 weeks of the trials. The injection protocol is given in Fig. 
5C. These results indicated that NCL was able to improve 
survival whether given early or late in disease development. 
The significant survival numbers for late NCL injections, 
when tumors were almost certainly initiated, augurs well for 
a more expansive study of delayed clinoptilolite treatments, 
in order to establish the translational potential of treatment 
regimens.
Figure S2 compares abdominal cavities of mice represent-
ing control saline or clinoptilolite mice, and mice treated with 
crocidolite or crocodolite plus clinoptilolite. Post‐mortems 
such as these revealed pinpoint tumors of 1‐3 mm diameter 
(Fig. S2iv), and swollen liver, dilated cecum, spleen enlarge-
ment, and organ adhesions. Except for occasional clinopti-
lolite deposits (Fig. S2ii), 21/29 asbestos plus clinoptilolite 
mice were normal to the naked eye. Epithelioid and sarcoma-
toid tumor histologies are shown in Fig. S3.
The few mice in the crocidolite + NCL subgroup that de-
veloped tumors showed identical liver histology to the mice 
injected with crocidolite alone (Fig. 6i‐v), but the liver histol-
ogy of all other crocidolite + NCL mice was identical to that 
of the saline and NCL controls (Fig. 6i‐iv).
There was clear evidence of free and phagocytosed cro-
cidolite fibers in spleen and liver (Fig. S4; Fig. 7). A total of 
42 free and 7 phagocytosed crocidolite fibers were counted 
in sections from asbestos‐injected mice taken at random from 
subgroups in both trials. In contrast, 12 free and 107 phago-
cytosed fibers were counted in spleen and liver sections from 
asbestos plus NCL mice (Fig. 7). Protection against asbestos 
carcinogenesis and increased survival was observed not only 
in all mice receiving weekly NCL for the entire 30‐week trial, 
but also when zeolites were given only for the first 10 weeks, 
or from week 10 onwards.
The expression of SV40 TAg indicates the effect of croci-
dolite asbestos in transforming mesothelial cells. There was 
a marked difference in the SV40‐positive mesothelial and 
SV40 negative Kupffer cells in mice treated with crocidolite 
alone or with crocidolite plus clinoptilolite (Fig. 8A). TAg 
was seen mainly in the nuclei of tumor cells (Fig. 8B; left 
histology panel). The reduced expression of SV40 TAg in 
crocidolite plus clinoptilolite‐treated mice might be caused 
by the amelioration of mesothelial cell transformation and 
thus a reduction in the initiation of mesothelioma. This study 
also detected the SV40 TAg inside Kupffer cells in the liver. 
Asbestos fibers were able to cause inflammation in both peri-
toneum and liver, but the Kupffer cells can only respond to 
F I G U R E  4  Mean expression levels of EGR1 and IL‐8, 
measured by RT‐qPCR, from cells treated with chrysotile (n = 12) 
and crocidolite (n = 4 assays), with or without natural clinoptilolite 
(checked bars) for 48 h. For all in vitro assays, asbestos was used at 
5 µg/cm2 and zeolites at 10 µg/cm2
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the inflammation inside the liver. After asbestos plus clinop-
tilolite treatment, TAg was seen mainly in the cytoplasm of 
some Kupffer cells in liver tissue (Fig. 8B; right panel), most 
likely due to phagocytosis of SV40 positive mesothelial cells, 
which is consistent with a similar observation in the orig-
inal description of this mouse model.20 There was no TAg 
expression in either saline or NCL‐treated mice (not shown). 
A thickened peritoneum covering the liver, indicative of an 
F I G U R E  5  A, Zeolites reduce asbestos‐induced mesothelioma formation in a mouse model. Mice were treated with crocidolite, NCL or a 
combination, and monitored for 30 wk. NCL30 and NCL90 are natural clinoptilolite at 30 and 90 mg/kg, respectively. Early NCL represents the 
subgroup of mice that were given weekly NCL injections until week 10, with late NCL the subgroup receiving NCL injections from week 10. One 
mouse in the late subgroup developed a foot infection and was culled at week 8. Incidence (y‐axis) represents the onset of mesothelioma. B, Kaplan 
Meier plots of surviving mice treated with crocidolite only (Croc; blue trace), or crocidolite plus clinoptilolite (Croc + Zeo; black trace). C, The 
timeline of treatments over the 30 wk of the trials are given here. Crocidolite was injected in weeks 1 and 4 only. Clinoptilolite was injected weekly 
in Trial 1, or for the first 10 wk or last 20 wk in Trial 2. KM plots are not shown for saline or clinoptilolite controls as all of these mice survived the 






































































F I G U R E  6  Sagittal liver sections from mice treated with: (i) saline; (ii) NCL30; (iii) NCL90; (iv) crocidolite plus NCL30; (v) crocidolite. 
In the last panel three asbestos fibers are arrowed. Saline and NCL‐treated control mice showed normal peritoneal lining of liver cells under HE 
staining, as did liver cells from mice injected with crocidolite plus NCL, whereas mice injected with crocidolite developed thickened peritoneum, 
liver swelling, and disorganisation. This was reflected in the tumor histology with a total of 14 mesothelial tumors among the five mice. The scale 
bar is 75 µm
(I) (II) (III) (IV) (V)
F I G U R E  7  Total counts of free or phagocytosed asbestos fibers in liver and spleen sections. For each organ, sections (10 fields at 40×) from 
6 asbestos and 12 asbestos plus NCL‐treated mice, were counted
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inflammatory reaction, was present in all asbestos‐treated 
mice. No such liver peritoneal swelling occurred in surviv-
ing asbestos plus NCL injected mice. The five asbestos plus 
NCL‐treated mice that developed tumors showed liver peri-
toneal thickening, but it was less evident than that seen in 
asbestos‐treated mice.
4 |  DISCUSSION
Our studies in vitro, and in an asbestos‐induced MM 
mouse model in vivo, support the results of previous stud-
ies demonstrating the ability of zeolites to prevent or delay 
carcinogenesis, but this is the first report of success in de-
laying or preventing MM in an animal model. In mice and 
dogs suffering from a variety of tumor types, zeolite injec-
tions (i.p.) led to improvements in overall health, life span, 
and decreases in tumor size.36 Micronized zeolite adminis-
tered by gastric intubation to mice injected with melanoma 
cells significantly reduced the number of melanoma metas-
tases,36 which suggests that zeolites might attenuate sur-
vival signals and induce tumor suppressor genes, notions 
that may be relevant to this study of asbestos‐induced MM. 
Sodium aluminosilicates, of which NCL is a derivative, are 
well tolerated and generally regarded as safe, and carcino-
genic effects have not been observed. In one dietary study 
in humans, NCL promoted the excretion of heavy metals 
in urine without removing vital electrolytes, and only very 
high doses (300 mg/kg) caused a focal storage type reac-
tion in lung tissue.37
The apparent safety of zeolites compared with asbestos, 
despite both being silicate minerals, may be related to their 
physical structure. Whereas asbestos is a fibrous material, 
most zeolites have orthorhombic crystalline structures with 
accessible open channels for water and large ions.21,22 The 
safety of zeolites and, in particular, clinoptilolite, has been 
tested in animals and humans, by ingestion or injection.36 
The European Food Safety Authority panel on additives in 
animal feed (2013) reported that clinoptilolite was non‐toxic 
at doses of 10 000 mg/kg.22 An earlier comprehensive tox-
icology study 38 used micronized clinoptilolite as a dietary 
supplement in rats and mice for up to one year, finding that 
doses of 1000 mg/mice/day elicited no apparent side effects 
or toxicity. In contrast, it is well known that the rod‐shaped or 
serpentine nature of asbestos fibers contributes to their toxic-
ity.33 It is apposite that the only known carcinogenic zeolite, 
namely erionite, also has a rod‐like structure,23-25 which is 
in contrast to the cage‐like geometries of other zeolites.21,26 
A recent in vitro study showed that extremely small carbon 
nanotubes, as 10‐20 µm rod‐shaped particles, suppress nor-
mal immune responses in human lung epithelial cells,39,40 or 
induce MM when administered to mice,40 mimicking what is 
seen with asbestos or erionite fibers. Interestingly, fullerenes 
do not generate the effects seen with nanocarbon rod‐shaped 
nanotubes, presumably because fullerenes have spherical/
ellipsoidal structure.41 Synthetic chrysotile‐like nanofibers, 
devoid of iron, did not elicit oxidative stress, nor exert geno-
toxic and cytotoxic effects in a murine alveolar macrophage 
cell line, whereas the same nanofibers, loaded with 0.94% 
(w/w) iron, induced DNA strand breaks, lipoperoxidation, 
and oxidative stress, similarly to natural chrysotile.42
In support of the iron sequestering capacity of zeolites, 
our earlier study in MexTAg299 mice showed that clinop-
tilolite prevented abdominal organ discoloration and cell 
damage caused by iron polymaltose injected i.p. twice 
weekly for 30 weeks.43 There is a link between the immune 
system and iron homeostasis, chiefly via interactions be-
tween the iron regulator hepcidin, storage protein ferritin, 
F I G U R E  8  A, Total counts of SV40‐positive mesothelial cells (first three bars), or SV40‐negative Kupffer cells (right three bars), from 
asbestos‐treated mice (black), asbestos plus NCL90 mice (light gray), and asbestos plus NCL30 mice (dark gray). Ten fields at 40× were counted, 
covering 80%‐100% of each slide. Asbestos‐treated mice showed higher numbers of SV40 positive mesothelial cells (65) than did asbestos plus 
NCL mice (29); and correspondingly lower numbers of SV40‐negative Kupffer cells (38 vs 152) for asbestos vs asbestos plus NCL mice. B, SV40 
immunohistochemistry on sections of mesotheliomas from an asbestos‐treated mouse (left panel), and liver tissue from an asbestos plus NCL‐
treated mouse (right). The dashed red lines depict SV40 antigen within the mesothelial nuclei (left), or blue counterstained Kupffer cell nuclei 
(right). SV40 antigen staining is more obvious in the Kupffer macrophages than in the mesothelial cells due to the much larger size of the former 
cells. The scale bar is 40 µm
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and iron exporter ferroportin.44 Hepcidin is produced in the 
liver by a variety of immune cells, including macrophages 
and lymphocytes.45 We see a link between these findings 
and exposure to asbestos fibers, which leads to the sup-
pression of the immune system and the generation of ROS, 
chiefly from labile Fe3+. In these circumstances, hepcidin 
is less able to remove iron. Mouse peritoneal macrophages 
exposed to Fe3+ in culture showed a marked decline in 
survival rate and an enhanced capacity for lipid peroxida-
tion.46 The electrical activity of macrophages may be com-
promised by the presence of Fe3+ derived from aberrant 
metabolic function or foreign sources such as asbestos, and 
this probably extends to the immune system generally. By 
restoring iron homeostasis, zeolites may stimulate the im-
mune system.22
The immunostimulatory effects of zeolites are well docu-
mented 36,47,48; and it is interesting to speculate on the inter-
action between zeolites, macrophages, and iron, given that 
there is a delicate balance of macrophages and free iron in 
mammals. Mouse peritoneal macrophages exposed to Fe3+ 
in culture showed a pronounced decline in survival.46 Mice 
injected intraperitoneally with clinoptilolite showed an in-
crease in the number of peritoneal macrophages,36 which the 
authors ascribed to increased activation of macrophages and 
stimulants of the immune system. In our earlier iron mouse 
model study,43 we showed that the number of iron‐contain-
ing liver macrophages in iron plus clinoptilolite‐treated mice 
was double that seen in iron‐only treated mice. Interestingly, 
turning to other models of cancer, it has been shown that 
PD‐1 expression correlates negatively with phagocytic po-
tency against tumor cells, and blockade of the PD‐1/PD‐L1 
in vivo increases phagocytosis by macrophages, reduces 
tumor growth and lengthens the survival of mice in mouse 
models of cancer in a macrophage‐dependent fashion.49 From 
the viewpoint of the present study, we would like to explore 
the density and polarity of tumor‐infiltrating macrophages 
relative to the treatment states. Factors underlying the mac-
rophage activation should also be studied. For example, are 
they interferon‐gamma dependent?
The continuing slow progress in identifying new treat-
ments for MM and asbestosis is a factor that underlines the 
potential of this study and its outcomes. Whilst animal stud-
ies are notoriously difficult to reproduce, we have demon-
strated similar statistically significant mouse survival rates 
in both of our pilot studies. Nevertheless, we acknowledge 
that this represents preliminary data and a better understand-
ing of the mechanisms underlying the modulating effects of 
clinoptilolite is needed. It would be of interest to know if the 
ROS induced by asbestos exposure is mutagenic and if so, 
whether the mutation burden is reduced by the presence of 
zeolite. This would be a difficult task to prove, as asbestos 
is not considered very mutagenic and the mutational burden 
in mesothelioma is low 50,51 but in‐depth transcriptomic and 
epigenomic analyses may reveal insights. Further research, 
including animal toxicology studies of clinoptilolite and tri-
als with larger numbers of mice, will be required before any 
potential clinical studies are considered.
This pilot study suggests that zeolites are capable of ame-
liorating or delaying asbestos‐induced damage. In vivo this 
appears to involve reversing macrophage suppression, thus en-
abling macrophages to clear asbestos fibers and iron by phago-
cytosis and to scavenge free or asbestos‐adsorbed iron, thereby 
reducing ROS production. Our results support previous studies 
suggesting that chelation and/or prevention of redox imbalance 
may be a way to ameliorate asbestos toxicity,17,52 but much 
more work is needed. While the notion of using one type of 
silicate mineral (zeolite) to counteract the deleterious effects 
of another (asbestos) is seemingly antithetical, the effects of 
zeolites demonstrated here point toward a potential means to 
reduce asbestos‐induced carcinogenesis. At this point, however, 
it is too early to speculate on the potential clinical application of 
our findings. Carefully planned additional studies to understand 
the mechanisms underlying the asbestos‐ameliorating effects 
of zeolites are required before any clinical testing can be con-
sidered. More importantly, such studies have the potential to 
shed further light on asbestos carcinogenesis and the role of the 
immune system in the development of mesothelioma, and may 
uncover new treatment targets.
ACKNOWLEDGEMENTS
This study was funded by philanthropic grants from the John T 
Reid Charitable Trusts and SPARK Sydney.
CONFLICT OF INTEREST
The authors declare no competing financial interests.
AUTHOR CONTRIBUTIONS
The work was planned by AMG, with contributions from 
G.R., J.R., X.F., K.S., and C.M. The experiments were per-
formed by X.F., C.M., K.S., T.J., and A.M.G. The manuscript 
was written by A.M.G., K.S., and G.R. Intellectual input was 
provided by J.R., G.R., C.R., K.S., and T.J.
NOVELTY STATEMENT
Asbestos inhalation causes malignant mesothelioma (MM) 
and lung cancer, essentially incurable diseases with few ef-
fective treatments and dismal prognosis. We investigated the 
ability of the zeolite clinoptilolite to counteract the effects of 
asbestos in human cell lines and an asbestos‐induced mouse 
model of MM. Clinoptilolite prevented asbestos‐induced 
cell death, ROS production and DNA degradation in vitro, 
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and significantly reduced MM development in vivo. Further 
exploration of the chemopreventive potential of zeolites is 
warranted.
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